HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Lost in transition: Care for adults with sickle cell disease ‘complex puzzle’
• Clinical interventions can prevent, minimize impact of VTE Stephan Moll, MD; Beth Waldron, MA
• Advances in gastroesophageal adenocarcinoma, pancreatic cancer highlight GI symposium David H. Ilson, MD, PhD
• Cancer immunology ‘Dream Team’ formed
• UK researcher receives award
• FDA grants ‘breakthrough’ designation for ibrutinib
• Home nutrition support can improve outcomes for patients with cancer
• FDA approves Kadcyla for late-stage breast cancer
• FDA approves Stivarga for patients with advanced GIST
• FDA approves generic version of Doxil
• FDA approves Pomalyst for patients with multiple myeloma
• A 38-year-old female with recurrent ependymoma Munir Ghesani, MD, FACNM; Walter Choi, MD; Rebecca Fisher, MD; Jennifer Choi, MD; Hrvoje Melinscak, MD
• Novel test predicted presence of BRCA mutations
• Sequential docetaxel improved OS, DFS
• Spin and bias common in breast cancer studies
• BRCA1/2 mutation associated with early menopause
• Ultrasonic testing ruled out blood clots in pregnant women
• Beta-blockers improved DFS, OS in patients with NSCLC
• Corticorelin acetate shows promise in peritumoral brain edema
• Inotuzumab/rituximab combination shows promise in NHL
• Therapy offers hope for durable remission in ATL
• Tumor boards had little effect on quality of cancer care
• Anticoagulant use predicted survival in metastatic castration-resistant prostate cancer
• Elderly men, African-Americans at increased risk for aggressive prostate cancer